|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 1/05/16 Emmaus Life Sciences, Inc. 10-K 9/30/15 77:6.5M S2 Filings LLC/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 869K
2: EX-3.1.3 Articles of Incorporation/Organization or Bylaws HTML 26K
3: EX-10.25 Material Contract HTML 72K
4: EX-10.26 Material Contract HTML 29K
5: EX-23.1 Consent of Experts or Counsel HTML 21K
6: EX-31.1 Certification -- §302 - SOA'02 HTML 27K
7: EX-31.2 Certification -- §302 - SOA'02 HTML 26K
8: EX-32.1 Certification -- §906 - SOA'02 HTML 22K
9: EX-32.2 Certification -- §906 - SOA'02 HTML 22K
16: R1 Document and Entity Information HTML 50K
17: R2 Consolidated Balance Sheets HTML 103K
18: R3 Consolidated Balance Sheets (Parenthetical) HTML 40K
19: R4 Consolidated Statements of Operations HTML 84K
20: R5 Consolidated Statements of Changes in HTML 58K
Stockholders' Deficit
21: R6 Consolidated Statements of Cash Flows HTML 112K
22: R7 Nature of Operations HTML 39K
23: R8 Summary of Significant Accounting Policies HTML 84K
24: R9 Discontinued Operations HTML 45K
25: R10 Convertible Debt and Equity Financings HTML 52K
26: R11 Derivative Liabilities HTML 38K
27: R12 Stockholders' Deficit HTML 121K
28: R13 Income Taxes HTML 46K
29: R14 Related Party Transactions HTML 66K
30: R15 Loss Per Share HTML 41K
31: R16 Commitments and Contingent Liabilities HTML 50K
32: R17 Significant Customers HTML 26K
33: R18 Subsequent Events HTML 61K
34: R19 Summary of Significant Accounting Policies HTML 127K
(Policies)
35: R20 Summary of Significant Accounting Policies HTML 51K
(Tables)
36: R21 Discontinued Operations (Tables) HTML 43K
37: R22 Convertible Debt and Equity Financings (Tables) HTML 41K
38: R23 Derivative Liabilities (Tables) HTML 34K
39: R24 Stockholders' Deficit (Tables) HTML 101K
40: R25 Income Taxes (Tables) HTML 44K
41: R26 Loss Per Share (Tables) HTML 38K
42: R27 Commitments and Contingent Liabilities (Tables) HTML 35K
43: R28 Subsequent Events (Tables) HTML 57K
44: R29 Nature of Operations (Details Narrative) HTML 48K
45: R30 Summary of Significant Accounting Policies HTML 30K
(Details)
46: R31 Summary of Significant Accounting Policies HTML 34K
(Details 1)
47: R32 Summary of Significant Accounting Policies HTML 61K
(Details Narrative)
48: R33 Discontinued Operations (Details) HTML 41K
49: R34 Discontinued Operations (Details 1) HTML 37K
50: R35 Convertible Debt and Equity Financings (Details) HTML 71K
51: R36 Convertible Debt and Equity Financings (Details HTML 110K
Narrative)
52: R37 Derivative Liabilities (Details) HTML 30K
53: R38 Derivative Liabilities (Details Narrative) HTML 58K
54: R39 Stockholders' Deficit (Details) HTML 31K
55: R40 Stockholders' Deficit (Details 1) HTML 43K
56: R41 Stockholders' Deficit (Details 2) HTML 94K
57: R42 Stockholders' Deficit (Details 3) HTML 44K
58: R43 Stockholders' Deficit (Details 4) HTML 56K
59: R44 Stockholders' Deficit (Details Narrative) HTML 69K
60: R45 Stockholders' Deficit (Details Narrative 1) HTML 136K
61: R46 Stockholders' Deficit (Details Narrative 2) HTML 44K
62: R47 Income Taxes (Details) HTML 39K
63: R48 Income Taxes (Details 1) HTML 43K
64: R49 Income Taxes (Details Narrative) HTML 27K
65: R50 Related Party Transactions (Details Narrative) HTML 171K
66: R51 Related Party Transactions (Details Narrative 1) HTML 198K
67: R52 Loss Per Share (Details) HTML 54K
68: R53 Commitments and Contingent Liabilities (Details) HTML 57K
69: R54 Commitments and Contingent Liabilities (Details HTML 53K
Narrative)
70: R55 Significant Customers (Details Narrative) HTML 31K
71: R56 Subsequent Events (Details) HTML 40K
72: R57 Subsequent Events (Details 1) HTML 38K
73: R58 Subsequent Events (Details 2) HTML 37K
74: R59 Subsequent Events (Details Narrative) HTML 60K
76: XML IDEA XML File -- Filing Summary XML 131K
75: EXCEL IDEA Workbook of Financial Reports XLSX 89K
10: EX-101.INS XBRL Instance -- cnso-20150930 XML 1.83M
12: EX-101.CAL XBRL Calculations -- cnso-20150930_cal XML 157K
13: EX-101.DEF XBRL Definitions -- cnso-20150930_def XML 752K
14: EX-101.LAB XBRL Labels -- cnso-20150930_lab XML 1.02M
15: EX-101.PRE XBRL Presentations -- cnso-20150930_pre XML 963K
11: EX-101.SCH XBRL Schema -- cnso-20150930 XSD 163K
77: ZIP XBRL Zipped Folder -- 0001615774-16-003804-xbrl Zip 152K
Exhibit 3.1.3
CERTIFICATE OF AMENDMENT OF
CERTIFICATE OF INCORPORATION OF
CNS RESPONSE, INC.
CNS Response, Inc., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware, does hereby certify:
FIRST: That at a meeting of the Board of Directors (the "Board") of CNS Response, Inc. (the "Corporation") on September 2, 2015, resolutions were duly adopted setting forth a proposed amendment of the Certificate of Incorporation of the Corporation:(i) approving of an increase in the number of authorized shares which the Corporation is authorized to issue from 180,000,000 to 500,000,000 (the "Share Increase"), and (ii) approving the change of the Corporation's name from CNS Response, Inc. to MYnd Analytics, Inc., and, declaring said amendments, as reflected in a single amendment (hereinafter the "Amendment"), to be advisable and calling for separate approvals of the stockholders of the Corporation for consideration thereof. The resolutions setting forth the proposed Amendment are substantially as follows:
RESOLVED, that the Certificate of Incorporation of the Corporation be amended by amending and restating the Article I thereof relating to the name change of the Corporation, so that, as amended and restated, Article I shall be and read in its entirety, as follows:
ARTICLE I
The name of the Corporation is MYnd Analytics, Inc.
RESOLVED, that the Certificate of Incorporation of the Corporation be amended by amending and restating the Article IV thereof relating to the authorized shares of the Corporation, so that, as amended and restated, Article IV shall be and read in its entirety, as follows:
ARTICLE IV
CAPITAL STOCK
Section 4.A. The total number of shares of stock which the Corporation shall have authority to issue is Five Hundred Fifteen Million (515,000,000).
Section 4.B. Common Stock. The total number of shares of common stock which the Corporation shall have authority to issue is Five Hundred Million (500,000,000) shares, with a par value of $0.001 per share. Stockholders shall not have preemptive rights or be entitled to cumulative voting in connection with the shares of the Corporation's Common Stock.
Section 4.C. Blank-Check Preferred Stock. The total number of shares of undesignated preferred stock which the Corporation shall have the authority to issue is Fifteen Million (15,000,000) shares, with a par value of $0.001 per share. The Board of Directors is hereby expressly authorized to provide, out of the unissued shares of preferred stock, for one or more series of preferred stock and, with respect to each such series, to fix the number of shares constituting such series and the designation of such series, the voting powers, if any, of the shares of such series, and the preferences and relative, participating, optional or other special rights, if any, and any qualifications, limitations or restrictions thereof, of the shares of such series. The powers, preferences and relative, participating, optional and other special rights of each series of preferred stock, and the qualifications, limitations or restrictions thereof, if any, may differ from those of any and all other series at any time outstanding.
SECOND: That thereafter, pursuant to resolution of its Board of Directors, an annual meeting of the stockholders of the Corporation was duly called and held on October 28, 2015 upon notice in accordance with section 222 of the General Corporation Law of the State of Delaware, pursuant to which a majority of each class of stockholders voted in favor of the Amendment.
THIRD: That said Amendment was duly adopted on October 28, 2015 in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware.
C:
FOURTH: That the capital of said Corporation shall not be reduced under or by reason of said Amendment.
IN WITNESS WHEREOF, the undersigned has executed this Certificate of Amendment of the Certificate of Incorporation of CNS Response, Inc. as of November 2, 2015.
| CNS RESPONSE, INC. | ||
| By: | /s/ George C. Carpenter IV | |
| Name: | George C. Carpenter IV | |
| Title: | President & Chief Executive Officer | |
C:
| - C: 2 - |
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 1/5/16 | |||
| 11/2/15 | ||||
| 10/28/15 | 8-K, DEF 14A | |||
| For Period end: | 9/30/15 | 8-K, CORRESP, NT 10-K, PRER14A | ||
| 9/2/15 | ||||
| List all Filings | ||||